Publications explained
116 publications in indexed journals · 14 as first author · 34 as senior author · 4 patents
Explained in plain language
Fifteen papers summarised without jargon, with full text where it is open.
3D-printed shape-morphing hydrogels recreating the corneal stem-cell niche
Acta Biomaterialia · 2026 · Senior author
The cornea renews itself thanks to stem cells nestled in tiny folds at its edge — the limbal crypts. We developed a simple light-based 3D-printing method, using a silk-and-collagen bioink, that builds undulating scaffolds mimicking those crypts in a single step. They supported corneal cell growth and organization for over three weeks — a promising route toward repairing the eye's surface.
DOI · PDF
Leprosy without borders: ocular and cutaneous manifestations beyond endemic areas
Ophthalmology · 2026 · Senior author
One month after successful cataract surgery, a patient from Congo developed nodules on the white of the eye and complete loss of corneal sensation with abnormally thickened nerves. The unexpected diagnosis in Paris: leprosy. The case is a reminder that so-called tropical diseases can appear anywhere and should stay on the clinician's radar when faced with unusual signs.
DOI · PDF
Severe corneal manifestations of graft-versus-host disease
The Ocular Surface · 2025 · Senior author
After a bone-marrow transplant, the grafted cells can turn against the recipient's body (graft-versus-host disease), including the eyes. Among 140 patients, nearly a quarter developed corneal ulcers or perforations, sometimes years later. Key message: these patients need close ophthalmic monitoring and must never receive anti-inflammatory (NSAID) eye drops, which markedly worsen these complications.
DOI · PDF
Ocular adverse events of antibody-drug conjugates used in cancer
Progress in Retinal and Eye Research · 2024 · First author
Antibody-drug conjugates (ADCs) are a new generation of cancer drugs that deliver their payload straight into tumour cells. Highly effective, they can nonetheless irritate the eyes: dryness, light sensitivity, corneal changes. This review explains why these effects occur and how to detect and manage them early — most are reversible with shared monitoring between ophthalmologists and oncologists.
DOI · PDF
Detecting subclinical corneal edema by thickness mapping in Fuchs endothelial corneal dystrophy
American Journal of Ophthalmology · 2023 · Senior author
Before cataract surgery, it is crucial to know whether a Fuchs-dystrophy patient's cornea is already subtly swollen (subclinical edema) — this helps decide whether to graft the endothelium at the same time. Analyzing the corneal thickness map (OCT) of 162 eyes, we identified simple measurements, at 5 and 7 mm from the centre, that reliably detect this early swelling and guide the surgical decision.
DOI · PDF
Cataract surgery in Fuchs dystrophy (cornea guttata): 10 practical tips
Clinical practice review · 2023 · Educational article
Fuchs dystrophy weakens the cornea's inner layer (the endothelium), which can decompensate and cloud over after cataract surgery. This practical review for ophthalmologists gathers ten tips: spotting cornea guttata before surgery, informing the patient of the risk, adapting the surgical technique, and knowing when to combine cataract surgery with an endothelial graft. The aim: operate at the right time and preserve corneal clarity.
PDF
Femtosecond “double-docking” DALK for advanced keratoconus: a case series
Cornea · 2023 · First author
Keratoconus thins and distorts the cornea. We followed 37 eyes treated with our “double-docking” technique, which replaces the diseased corneal layers while preserving the innermost one. Vision improved markedly in the large majority of patients. The main obstacle to success: pre-existing corneal scarring, which prevents the air bubble used to cleanly separate the layers.
PDF
Pterygium surgery: conjunctival autograft vs amniotic membrane — a 30-year review
Ophthalmology and Therapy · 2023 · Senior author
Pterygium is an overgrowth of the conjunctiva onto the cornea that often recurs after surgery. Synthesizing 30 years of studies (nearly 3,750 eyes), we show that fixing the graft with fibrin glue rather than sutures markedly lowers recurrence, and that combining a conjunctival autograft with an amniotic membrane gives the best results.
DOI · PDF
Severe corneal involvement associated with mpox infection
JAMA Ophthalmology · 2023 · Senior author
During the mpox outbreak, eye involvement was thought to be rare and mild. We report two cases of severe corneal involvement to alert ophthalmologists: recognizing these complications early helps avoid inappropriate treatment and protect vision.
DOI · PDF
A meganuclease targeting HSV-1: toward herpes-protected corneal transplants
Molecular Therapy — Nucleic Acids · 2022 · Senior author
Herpes (HSV-1) is a leading cause of corneal blindness, and grafts often fail because the virus recurs. We engineered a meganuclease — a molecular scissor that specifically cuts the virus's DNA — delivered by gene therapy. In human corneas and an animal model, the modified grafts resisted infection: a new route to durably protect transplant patients.
DOI · PDF
Neurotrophic keratitis: frequency, causes and management
The Ocular Surface · 2020 · Senior author
Neurotrophic keratitis occurs when the cornea loses sensation (often after herpes) and no longer heals properly. Reviewing over 300,000 records, we found it is more common than previously reported and too often diagnosed late. Early, tailored management — amniotic membrane, autologous serum, targeted treatments — markedly improves visual outcomes.
DOI · PDF
The femtosecond “double-docking” technique for deep anterior lamellar keratoplasty
Cornea · 2018 · Senior author
To replace the damaged corneal layers while keeping the innermost one (safer than a full-thickness graft), we combine a high-precision femtosecond laser with real-time OCT imaging. This “double-docking” technique makes the cut more regular, safer and reproducible, with no perforation in the reported cases.
PDF
Sclerocorneal intrastromal lamellar keratoplasty for pellucid marginal degeneration
Cornea · 2016 · Senior author
Pellucid marginal degeneration thins the cornea near its edge and severely distorts vision (high astigmatism). We propose inserting, through a small scleral tunnel under OCT guidance, a thin corneal lamella to re-thicken the weakened zone and correct the distortion — here more than 11 dioptres corrected, without complications.
PDF
Modified deep anterior lamellar keratoplasty for epithelialized descemetoceles
Cornea · 2011 · First author
When a corneal ulcer worsens, it can erode down to the eye's thin inner membrane (Descemet's membrane), on the verge of perforation: a descemetocele. We describe an air-assisted lamellar graft technique that removes the weakened area and replaces it without fully opening the eye. Vision improved from “counting fingers” to 20/40, stable for at least a year.
PDF
Fluorescent in situ hybridization (FISH) on corneal impression cytology specimens: epithelial cell survival after keratoplasty
Investigative Ophthalmology & Visual Science · 2011 · Senior author
After a corneal graft between a donor and recipient of different sex, donor epithelial cells can be tracked using sex-chromosome labelling (FISH), sampled simply with a corneal impression. In 35 grafted patients, donor cells persisted at the centre of the graft for more than 211 days, with a median survival of 385 days — longer than previously thought — and appeared to persist somewhat longer under topical 2% cyclosporine.
DOI · PDF
Complete list of works
References as listed in the curriculum, impact factor from the 2024 Journal Citation Reports.
- Ferreira de Moura T, Clavel G, Gabison EE. Leprosy without Borders: Ocular and Cutaneous Manifestations beyond Endemic Areas. Ophthalmology. 2026;133(8):e110. IF 9,5
- Paschalidis I, Chatelain F, Agniel R, Sandt C, Guindolet D, Kellouche S, Fuchs A, Souquet B, Gabison EE. Digital light processing programs shape-morphing hydrogels into undulating 3D scaffolds supporting corneal limbal epithelial organization. Acta Biomater. 2026;218:310-322. IF 9,6
- Gaulier A, Jaworski T, Vautier A, Lefevre S, Chaventre F, Toubeau D, Sabourin JC, Gabison É, Gueudry J, Boyer O, Muraine M. Development of an Ex Vivo Model of Focal Corneal Desiccation to Investigate the Pathophysiology of Corneal Dellen and Ulcers. Cornea. 2026;45(4):504-512. IF 2,1
- Bourdin A, Gournay V, Doan S, Prata PH, Kaphan E, Michonneau D, Socié G, Peffault de Latour R, Gabison EE. Severe corneal manifestations of graft-versus-host disease: Experience of a tertiary referral center. Ocul Surf. 2025;36:19-24. IF 5,6
- Clariot S, Moures JM, Lopes L, Gatinel D, Gabison E, Nicolaos G, Salomon L, Devys JM. Centralized monitored anesthesia care by nurse anesthetist for cataract and glaucoma surgery in a 1:3 ratio: a non-inferiority study. Minerva Anestesiol. 2025;91(3):176-183. IF 2,8
- Woodward AM, Guindolet D, Martinez-Carrasco R, Gabison EE, Lavker RM, Argüeso P. Low fucosylation defines the glycocalyx of progenitor cells and melanocytes in the human limbal stem cell niche. Stem Cell Reports. 2025;20(1):102378. IF 5,0
- Gabison EE, Rousseau A, Labetoulle M, Gazzah A, Besse B. Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategies. Prog Retin Eye Res. 2024;103:101302. IF 14,7
- Gaulier A, Guindolet D, Dovigo J, Cochereau I, Gabison E, Stéphan S. Central serous chorioretinopathy after Descemet's membrane endothelial keratoplasty. J Fr Ophtalmol. 2024;47(8):104219. IF 1,1
- Martin GC, Guindolet D, Gabison E. Lisch epithelial corneal dystrophy: A misdiagnosed clinical entity? J Fr Ophtalmol. 2024;47(7):104245. IF 1,1
- Gaulier A, Guindolet D, Cochereau I, Gabison E, Stéphan S. [Alport syndrome presenting as posterior polymorphous corneal dystrophy: Case report]. J Fr Ophtalmol. 2024;47(7):104204. IF 1,1
- Hallali G, Guindolet D, Gabison EE, Cochereau I, Doan S. Immediate and Delayed Effects of Punctal Plug Insertion on Tear Meniscus Height in Severe Aqueous-Deficient Dry Eye. Cornea. 2024;43(7):890-894. IF 2,1
- Vaitinadapoulé H, Poinard S, He Z, Pascale-Hamri A, Thomas J, Gain P, Thuret JY, Mascarelli F, Thuret G, French Fuchs Study Group. Nanotopography by chromatic confocal microscopy of the endothelium in Fuchs endothelial corneal dystrophy, pseudophakic bullous keratopathy and healthy corneas. Br J Ophthalmol. 2024;108(8):1184-1192. IF 3,5
- Martin GC, Brassier A, Gabison E. In vivo corneal confocal microscopy revealing Gaucher disease in a child. Can J Ophthalmol. 2024;59(3):e265. IF 2,8
- Amar J, El Kaim P, Scemla B, Boumendil J, Chotard G, Gabison E, Bouheraoua N. [Corneal perforations in patients on tyrosine kinase inhibitors]. J Fr Ophtalmol. 2023;46(9):1111-1113. IF 1,1
- Desira M, Gabison E, Jacomet PV, Denis D, Dalmas F, David T, Aziz A. A new treatment changes the game: An innovative management of a child suffering from severe ligneous conjunctivitis with type 1 plasminogen deficiency. Ocul Surf. 2023;30:320-321. IF 5,6
- Gabison EE, Gree E, Azar G, Cochereau I, Guindolet D. Double-Docking Technique for Femtosecond Laser-Assisted Deep Anterior Lamellar Keratoplasty: A Retrospective Consecutive Case Series Study of Advanced Keratoconus. Cornea. 2023;42(8):1052-1056. IF 2,1
- Gargouri MA, Yousfi N, Toutain J, Farès S, Lejoyeux R, Gabison E, Cochereau I, Titah C, Azar G. Multiple Evanescent White Dot Syndrome Following COVID-19 mRNA Vaccination. Ocul Immunol Inflamm. 2023;31(6):1240-1244. IF 2,0
- Vautier A, Bourges JL, Gabison E, Chaventre F, Lefevre S, Toubeau D, Arnoult C, Albou-Ganem C, Boyer O, Muraine M. An Efficient Technique for the Long-term Preservation of SMILE Lenticules Using Desiccation. J Refract Surg. 2023;39(7):491-498. IF 3,0
- Paganelli B, Sahyoun M, Gabison E. Conjunctival and Limbal Conjunctival Autograft vs. Amniotic Membrane Graft in Primary Pterygium Surgery: A 30-Year Comprehensive Review. Ophthalmol Ther. 2023;12(3):1501-1517. IF 3,2
- Guindolet D, Disegni H, Martin GC, Azar G, Hardy S, Cochereau I, Gabison EE. Predictive factors of graft detachment and rebubbling after descemet membrane endothelial keratoplasty. Int Ophthalmol. 2023;43(5):1511-1521. IF 1,4
- Doan S, Houry R, Cristea I, Boughar B, Cochereau I, Gabison EE, Guindolet D. Severe Corneal Involvement Associated With Mpox Infection. JAMA Ophthalmol. 2023;141(4):402-403. IF 9,2
- Guindolet D, Huynh O, Martin GC, Disegni H, Azar G, Cochereau I, Gabison E. Cystoid macular oedema after descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2023;107(4):470-475. IF 3,5
- Guindolet D, Gemahling A, Azar G, Disegni H, Samie M, Cochereau I, Gabison EE. Detecting Subclinical Corneal Edema Using Corneal Thickness Mapping in Patients Presenting Fuchs Endothelial Corneal Dystrophy. Am J Ophthalmol. 2023;246:58-65. IF 4,2
- Thorel D, Ingen-Housz-Oro S, Benaïm D, Daien V, Gabison E, Saunier V, Béral L, Touboul D, Brémond-Gignac D, Robert M, Vasseur R, Royer G, Dereure O, Milpied B, Bernier C, Welfringer-Morin A, Bodemer C, Cordel N, Tauber M, Burillon C, Servant M, Couret C, Vabres B, Tétart F, Cassagne M, Kuoch MA, Muraine M, Delcampe A, Gueudry J. Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management. Orphanet J Rare Dis. 2023;18(1):51. IF 3,5
- Ingen-Housz-Oro S, Schmidt V, Ameri MM, Abe R, Brassard A, Mostaghimi A, Paller AS, Romano A, Didona B, Kaffenberger BH, Ben Said B, Thong BYH, Ramsay B, Brezinova E, Milpied B, Mortz CG, Chu CY, Sotozono C, Gueudry J, Fortune DG, Dridi SM, Tartar D, Do-Pham G, Gabison E, Phillips EJ, Lewis F, Salavastru C, Horvath B, Dart J, Setterfield J, Newman J, Schulz JT, Delcampe A, Brockow K, Seminario-Vidal L, Jörg L, Watson MP, Gonçalo M, Lucas M, Torres M, Noe MH, Hama N, Shear NH, O'Reilly P, Wolkenstein P, Romanelli P, Dodiuk-Gad RP, Micheletti RG, Tiplica GS, Sheridan R, Rauz S, Ahmad S, Chua SL, Flynn TH, Pichler W, Le ST, Maverakis E, Walsh S, French LE, Brüggen MC. Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus. Orphanet J Rare Dis. 2023;18(1):33. IF 3,5
- Chapellier B, Guindolet D, Pereira D, Galetto R, Sahel JA, Labetoulle M, Gabison EE. Meganuclease targeting HSV-1 protects against herpetic keratitis: Application to corneal transplants. Mol Ther Nucleic Acids. 2022;30:511-521. IF 6,1
- Guillon-Rolf R, Guindolet D, Gabison EE. Outpatient vs. inpatient Descemet's membrane endothelial keratoplasty: Changing practice patterns in a COVID-19 environment. J Fr Ophtalmol. 2022;45(7):e314-e315. IF 1,1
- Guindolet D, Gemahling A, Rousseau A, Nguyen Kim P, Azar G, Martin GC, Cochereau I, Labetoulle M, Gabison EE. Clinical course and treatment of archipelago keratitis: a Herpesviridae keratitis subtype. Br J Ophthalmol. 2022:bjophthalmol-2021-320847. IF 3,5
- Gabison EE, Guindolet D. Neurotrophic Keratitis: A rare disease that requires proactive screening and orphan drug treatments. Ocul Surf. 2022;25:154. IF 5,6
- Bremond-Gignac D, Robert M, Daruich A, Borderie V, Chiambaretta F, Valleix S, Groupe Redacteur Relecteur PNDS Aniridie. [National protocol for diagnosis and care of congenital aniridia: Summary for the attending physician]. J Fr Ophtalmol. 2022;45(6):647-652. IF 1,1
- Guindolet D, Woodward AM, Gabison EE, Argüeso P. Glycogene Expression Profile of Human Limbal Epithelial Cells with Distinct Clonogenic Potential. Cells. 2022;11(9):1575. IF 5,2
- Audelan T, Martin G, Marciano E, Gillard P, Azar G, Cochereau I, Gabison E, Doan S. Clinical, Meibographic, and Interferometric Evaluation in Children With Ocular Rosacea. Am J Ophthalmol. 2022;237:13-21. IF 4,2
- Guindolet D, Woodward AM, Gabison EE, Argüeso P. Alleviation of Endoplasmic Reticulum Stress Enhances Human Corneal Epithelial Cell Viability under Hyperosmotic Conditions. Int J Mol Sci. 2022;23(9):4528. IF 4,9
- Bohelay G, Alexandre M, Le Roux-Villet C, Sitbon I, Doan S, Soued I, Shourick J, Rousset L, Mellottee B, Heller M, Lièvre N, Zumelzu C, Morin F, Grootenboer-Mignot S, Gabison E, Caux F, Prost-Squarcioni C, Musette P. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients. Front Immunol. 2022;13:915205. IF 5,9
- Cohen F, Gabison EE, Stéphan S, Belkhir R, Nocturne G, Best AL, Haigh O, Barreau E, Labetoulle M, Seror R, Rousseau A. Peripheral ulcerative keratitis in rheumatoid arthritis patients taking tocilizumab: paradoxical manifestation or insufficient efficacy? Rheumatology (Oxford). 2021;60(11):5413-5418. IF 4,4
- Stéphan S, Cohen F, Salviat F, Thevenin S, Devys JM, Cochereau I, Gabison E. Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes. Ocul Surf. 2021;22:13-14. IF 5,6
- Boutillier G, Bernheim D, Denoyer A, Gabison E, Sitbon C, Hacquard M, Muraine M. Refractive accuracy and visual outcomes after combined descemet membrane endothelial keratoplasty and cataract surgery: A French multicentric study. J Fr Ophtalmol. 2021;44(6):792-798. IF 1,1
- Martin GC, Bernabe-Gelot A, Gabison E. In Vivo Corneal Confocal Microscopy in Mucolipidosis Type IV. Ophthalmology. 2021;128(4):521. IF 9,5
- Martin GC, Le Roux G, Guindolet D, Boulanger E, Hasle D, Morin E, Vodovar D, Vignal C, Gabison E, Descatha A, French PCC Research Group. Pediatric Eye Injuries by Hydroalcoholic Gel in the Context of the Coronavirus Disease 2019 Pandemic. JAMA Ophthalmol. 2021;139(3):348-351. IF 9,2
- Guindolet D, Crouzet E, He Z, Herbepin P, Perrache C, Garcin T, Gauthier AS, Forest F, Peoc'h M, Gain P, Gabison E, Thuret G. Epithelial Regeneration in Human Corneas Preserved in an Active Storage Machine. Transl Vis Sci Technol. 2021;10(2):31. IF 2,6
- Egri S, Van Hollebecke I, Guindolet D, Manenti C, Rougier H, Gabison É, Cochereau I, Doan S. [Efficacy of intense pulsed light therapy in the treatment of Meibomian gland dysfunction-related severe dry eye]. J Fr Ophtalmol. 2021;44(2):169-175. IF 1,1
- Bonnet I, Rousseau A, Duraffour P, Pouchot J, Nguyen CD, Gabison E, Seror R, Marotte H, Mariette X, Nocturne G. Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis. RMD Open. 2021;7(1):e001472. IF 4,7
- Farhat R, Clavel G, Villeneuve D, Abdelmassih Y, Sahyoun M, Gabison E, Sené T, Cochereau I, Titah C. Sustained Remission with Tocilizumab in Refractory Relapsing Polychondritis with Ocular Involvement: A Case Series. Ocul Immunol Inflamm. 2021;29(1):9-13. IF 2,0
- Martin GC, Vabres B, Dureau P, Lebranchu P, Caputo G, Gabison E. Comment on Descemet Stripping Endothelial Keratoplasty in Pediatric Patients with Congenital Hereditary Endothelial Dystrophy. Am J Ophthalmol. 2020;215:155. IF 4,2
- Denier M, Gabison E, Sahyoun M, Labetoulle M, Dureau P, Cochereau I, Doan S. Stromal Keratitis After Varicella in Children. Cornea. 2020;39(6):680-684. IF 2,1
- Guindolet D, Gabison EE. Role of CD147 (EMMPRIN/Basigin) in Tissue Remodeling. Anat Rec (Hoboken). 2020;303(6):1584-1589. IF 2,1
- Bourrienne MC, Loyau S, Faille D, de Raucourt E, de Mazancourt P, Ho-Tin-Noé B, Gabison E, Ajzenberg N. Functional Fibrinolysis Assays Reveal Different Mechanisms underlying Plasminogen Dysfunction in Ligneous Conjunctivitis. Thromb Haemost. 2020;120(5):758-767. IF 4,3
- Martin GC, de Lonlay P, Chapron T, Cochereau I, Caputo G, Gabison E. Bilateral dendriform ulcer leading to an early diagnosis of tyrosinemia type 2. J AAPOS. 2020;24(2):120-122. IF 1,3
- Saad S, Abdelmassih Y, Saad R, Guindolet D, Khoury SE, Doan S, Cochereau I, Gabison EE. Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomes. Ocul Surf. 2020;18(2):231-236. IF 5,6
- Elbaz E, Martin GC, Gabison E. Central Corneal Pyogenic Granuloma in Aniridia. Ophthalmology. 2020;127(2):197. IF 9,5
- Rousseau A, Prost-Squarcioni C, Doan S, Leroux-Villet C, Caux F, Hoang-Xuan T, Cochereau I, Gabison E. Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up. Br J Ophthalmol. 2020;104(2):235-240. IF 3,5
- Lam D, Villaret J, Nguyen Kim P, Gabison E, Cochereau I, Doan S. In Vivo Confocal Microscopy of Prominent Conjunctival and Corneal Nerves in Multiple Endocrine Neoplasia Type 2B. Cornea. 2019;38(11):1453-1455. IF 2,1
- Clavel G, Gabison E, Semerano L. Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views. Joint Bone Spine. 2019;86(6):699-705. IF 4,3
- Maillard A, Alby C, Gabison E, Doan S, Caux F, Bodemer C, Hadj-Rabia S. P63-related disorders: Dermatological characteristics in 22 patients. Exp Dermatol. 2019;28(10):1190-1195. IF 3,1
- Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA. Corrigendum to TFOS DEWS II pathophysiology report. Ocul Surf. 2019;17(4):842. IF 5,6
- Thorel D, Delcampe A, Ingen-Housz-Oro S, Hajj C, Gabison E, Chosidow O, Wolkenstein P, Royer G, Ezzedine K, Muraine M, Gueudry J. Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2019;181(1):212-213. IF 9,6
- Abdelmassih Y, Dubrulle P, Sitbon C, El-Khoury S, Guindolet D, Doan S, Labetoulle M, Cochereau I, Gabison EE. Therapeutic Challenges and Prognosis of Descemet's Membrane Endothelial Keratoplasty in Herpes Simplex Eye Disease. Cornea. 2019;38(5):553-558. IF 2,1
- Famery N, Abdelmassih Y, El-Khoury S, Guindolet D, Cochereau I, Gabison EE. Artificial chamber and 3D printed iris: a new wet lab model for teaching Descemet's membrane endothelial keratoplasty. Acta Ophthalmol. 2019;97(2):e179-e183. IF 2,8
- Boudhabhay I, Titah C, Talbot A, Harel S, Verine J, Touchard G, Kaaki S, Gabison E, Vasseur V, Mauget-Faÿsse M, Sené T. Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: A case report. Medicine (Baltimore). 2018;97(52):e13638. IF 1,4
- Stéphan S, Barral M, Guindolet D, Blanc R, Piotin M, Rouger H, Cochereau I, Gabison E. Asymptomatic neurotrophic keratitis in carotid-cavernous fistulae. Acta Ophthalmol. 2018;96(7):e895-e896. IF 2,8
- Abdelmassih Y, El-Khoury S, Georges S, Guindolet D, Gabison E, Cochereau I. Reply. J Cataract Refract Surg. 2018;44(10):1296-1297. IF 3,2
- Bonini S, Lambiase A, Rama P, Filatori I, Allegretti M, Chao W, Mantelli F, REPARO Study Group. Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. Ophthalmology. 2018;125(9):1468-1471. IF 9,5
- Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, Mantelli F, REPARO Study Group. Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. Ophthalmology. 2018;125(9):1332-1343. IF 9,5
- Gutierrez-Bonet R, Ruiz-Medrano J, Peña-Garcia P, Catanese M, Sadeghi Y, Hashemi K, Gabison E, Ruiz-Moreno JM. Macular Choroidal Thickening in Keratoconus Patients: Swept-Source Optical Coherence Tomography Study. Transl Vis Sci Technol. 2018;7(3):15. IF 2,6
- Abdelmassih Y, El-Khoury S, Georges S, Guindolet D, Gabison E, Cochereau I. Preoperative spectral-domain optical coherence tomography in patients having cataract surgery. J Cataract Refract Surg. 2018;44(5):610-614. IF 3,2
- Guindolet D, Nguyen DT, Bergin C, Doan S, Cochereau I, Gabison EE. Double-Docking Technique for Femtosecond Laser-Assisted Deep Anterior Lamellar Keratoplasty. Cornea. 2018;37(1):123-126. IF 2,1
- Guindolet D, Crouzet E, He Z, Herbepin P, Jumelle C, Perrache C, Dumollard JM, Forest F, Peoc'h M, Gain P, Gabison E, Thuret G. Storage of Porcine Cornea in an Innovative Bioreactor. Invest Ophthalmol Vis Sci. 2017;58(13):5907-5917. IF 4,7
- Rousseau A, Boutolleau D, Titier K, Bourcier T, Chiquet C, Weber M, Colin J, Gueudry J, M'Garrech M, Bodaghi B, Burrel S, Agut H, Deback C, HEDGOF, Labetoulle M. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study. Antiviral Res. 2017;146:205-212. IF 4,0
- Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438-510. IF 5,6
- Doan S, Amat F, Gabison E, Saf S, Cochereau I, Just J. Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature. Ophthalmol Ther. 2017;6(1):195-206. IF 3,2
- Benoist D'azy C, Gabison E, Sapin V, Bosc C, Pereira B, Chiambaretta F. [Descemet's membrane endothelial keratoplasty (DMEK): Analysis of a variation in Descemet's endothelial graft preparation]. J Fr Ophtalmol. 2017;40(5):371-385. IF 1,1
- Hardy S, Hashemi K, Catanese M, Candil M, Zufferey P, Gabison E, Guex-Crosier Y. Necrotising Scleritis and Peripheral Ulcerative Keratitis Associated with Rheumatoid Arthritis Treated with Rituximab. Klin Monbl Augenheilkd. 2017;234(4):567-570. IF 0,7
- Guindolet D, Reynaud C, Clavel G, Belangé G, Benmahmed M, Doan S, Hayem G, Cochereau I, Gabison EE. Management of severe and refractory Mooren's ulcers with rituximab. Br J Ophthalmol. 2017;101(4):418-422. IF 3,5
- Guindolet D, Badaoui A, Elluard M, Stephan S, Doan S, Cochereau I, Gabison EE. Unusual Severe Interface Inflammation After Uneventful Small Incision Lenticule Extraction (SMILE). J Refract Surg. 2016;32(12):855-857. IF 3,0
- Guindolet D, Petrovic A, Doan S, Cochereau I, Gabison EE. Sclerocorneal Intrastromal Lamellar Keratoplasty for Pellucid Marginal Degeneration. Cornea. 2016;35(6):900-903. IF 2,1
- Rossi P, Delcampe A, Gueudry J, Duncombe A, Gabison E, Doan S, Muraine M. [Gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease]. J Fr Ophtalmol. 2015;38(9):793-799. IF 1,1
- Rousseau A, Labbé A, Baudouin C, Cochereau I, Gabison E, Doan S. In vivo confocal microscopy and spectral domain anterior segment OCT in Lisch epithelial corneal dystrophy. J Fr Ophtalmol. 2015;38(7):e151-3. IF 1,1
- Huet E, Gabison E, Vallee B, Mougenot N, Linguet G, Riou B, Jarosz C, Menashi S, Besse S. Deletion of extracellular matrix metalloproteinase inducer/CD147 induces altered cardiac extracellular matrix remodeling in aging mice. J Physiol Pharmacol. 2015;66(3):355-366. IF 1,7
- Mauris J, Dieckow J, Schob S, Pulli B, Hatton MP, Jeong S, Bauskar A, Gabison E, Nowak R, Argüeso P. Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland. Cell Death Dis. 2015;6:e1726. IF 9,6
- Guindolet D, Amaouche N, Doan S, Cochereau I, Gabison É. [Mucus Fishing syndrome: case report and literature review]. J Fr Ophtalmol. 2015;38(3):e47-8. IF 1,1
- Labbé A, Gabison E, Brignole-Baudouin F, Riancho L, Menashi S, Baudouin C. Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments. Curr Eye Res. 2015;40(1):40-47. IF 2,0
- Khaddam M, Huet E, Vallée B, Bensidhoum M, Le Denmat D, Filatova A, Jimenez-Rojo L, Ribes S, Lorenz G, Morawietz M, Rochefort GY, Kiesow A, Mitsiadis TA, Poliard A, Petzold M, Gabison EE, Menashi S, Chaussain C. EMMPRIN/CD147 deficiency disturbs ameloblast-odontoblast cross-talk and delays enamel mineralization. Bone. 2014;66:256-266. IF 3,6
- Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, Agut H, Gabison EE. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis. J Clin Virol. 2013;58(1):321-324. IF 3,4
- Doan S, Gabison E, Chiambaretta F, Touati M, Cochereau I. Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis. J Ophthalmic Inflamm Infect. 2013;3(1):38. IF 2,3
- Gabison E, Khayati F, Mourah S, Menashi S. Cell membrane vesicles as a tool for the study of direct epithelial-stromal interaction: lessons from CD147. Methods Mol Biol. 2013;1066:103-111. IF n.d.
- Gabison EE, Doan S, Catanese M, Chastang P, Ben M'hamed M, Cochereau I. Modified deep anterior lamellar keratoplasty in the management of small and large epithelialized descemetoceles. Cornea. 2011;30(10):1179-1182. IF 2,1
- Huet E, Vallée B, Delbé J, Mourah S, Prulière-Escabasse V, Tremouilleres M, Kadomatsu K, Doan S, Baudouin C, Menashi S, Gabison EE. EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. Am J Pathol. 2011;179(3):1278-1286. IF 3,6
- Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, Caux F, Pascal F, Doan S, Brette MD, Soued I, Gabison É, Aucouturier F, Letestu R, Laroche L, Bachelez H. Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol. 2011;147(7):843-849. IF 4,8
- Labbé A, Gabison E, Cochereau I, Baudouin C. Diagnosis of fungal keratitis by in vivo confocal microscopy: a case report. Eye (Lond). 2011;25(7):956-958. IF 3,2
- Jorgensen C, Deschaseaux F, Planat-Benard V, Gabison E. [Mesenchymal stem cells: A therapeutic update]. Med Sci (Paris). 2011;27(3):275-284. IF 0,4
- Catanese M, Popovici C, Proust H, Hoffart L, Matonti F, Cochereau I, Conrath J, Gabison EE. Fluorescent in situ hybridization (FISH) on corneal impression cytology specimens (CICS): study of epithelial cell survival after keratoplasty. Invest Ophthalmol Vis Sci. 2011;52(2):1009-1013. IF 4,7
- Gayat E, Gabison E, Devys JM. Case report: bilateral angle closure glaucoma after general anesthesia. Anesth Analg. 2011;112(1):126-128. IF 3,8
- Azar G, Doan S, Cochereau I, Gabison EE. Management of post-LASIK recurrent epithelial ingrowth with flap melting using annular amniotic membrane graft. J Cataract Refract Surg. 2010;36(12):2207-2208. IF 3,2
- Gabison E, Hoang-Xuan T. [Scleritis: when might a systemic disease be involved?]. J Fr Ophtalmol. 2010;33(8):593-598. IF 1,1
- Gabison EE, Labbé A, Brignole-Baudouin F, Nourry H, Putterman M, Malecaze F, Hoang-Xuan T, Baudouin C. Confocal biomicroscopy of corneal intraepithelial neoplasia regression following interferon alpha 2b treatment. Br J Ophthalmol. 2010;94(1):134-135. IF 3,5
- Bougatef F, Quemener C, Kellouche S, Naïmi B, Podgorniak MP, Millot G, Gabison EE, Calvo F, Dosquet C, Lebbé C, Menashi S, Mourah S. EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood. 2009;114(27):5547-5556. IF 23,1
- Labbé A, Khammari C, Dupas B, Gabison E, Brasnu E, Labetoulle M, Baudouin C. Contribution of in vivo confocal microscopy to the diagnosis and management of infectious keratitis. Ocul Surf. 2009;7(1):41-52. IF 5,6
- Gabison EE, Huet E, Baudouin C, Menashi S. Direct epithelial-stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond. Prog Retin Eye Res. 2009;28(1):19-33. IF 14,7
- Lemarinel B, Gabison E, Doan S, Teyssot N, Hoang-Xuan T. [Anterior-segment indocyanine green angiography in the management of anterior scleritis]. J Fr Ophtalmol. 2008;31(5):495-501. IF 1,1
- Huet E, Vallée B, Szul D, Verrecchia F, Mourah S, Jester JV, Hoang-Xuan T, Menashi S, Gabison EE. Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J. 2008;22(4):1144-1154. IF 4,2
- Huet E, Gabison EE, Mourah S, Menashi S. Role of emmprin/CD147 in tissue remodeling. Connect Tissue Res. 2008;49(3):175-179. IF 2,1
- Gabison EE, Alfonsi N, Doan S, Racine L, Sultan G, Baudouin C, Hoang-Xuan T. Archipelago keratitis: a clinical variant of recurrent herpetic keratitis? Ophthalmology. 2007;114(11):2000-2005. IF 9,5
- Doan S, Gabison E, Abitbol O, Gatinel D, Chast F, Hoang-Xuan T. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis]. J Fr Ophtalmol. 2007;30(7):697-701. IF 1,1
- Doan S, Gabison EE, Nghiem-Buffet S, Abitbol O, Gatinel D, Hoang-Xuan T. Long-term visual outcome of childhood blepharokeratoconjunctivitis. Am J Ophthalmol. 2007;143(3):528-529. IF 4,2
- Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion. Cancer Res. 2007;67(1):9-15. IF 16,6
- Doan S, Gabison E, Gatinel D, Duong MH, Abitbol O, Hoang-Xuan T. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Am J Ophthalmol. 2006;141(1):62-66. IF 4,2
- Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 2005;87(3-4):361-368. IF 3,0
- Gabison EE, Mourah S, Steinfels E, Yan L, Hoang-Xuan T, Watsky MA, De Wever B, Calvo F, Mauviel A, Menashi S. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction. Am J Pathol. 2005;166(1):209-219. IF 3,6
- Gabison E, Chang JH, Hernández-Quintela E, Javier J, Lu PC, Ye H, Kure T, Kato T, Azar DT. Anti-angiogenic role of angiostatin during corneal wound healing. Exp Eye Res. 2004;78(3):579-589. IF 2,7
- Gabison EE, Chastang P, Menashi S, Mourah S, Doan S, Oster M, Mauviel A, Hoang-Xuan T. Late corneal perforation after photorefractive keratectomy associated with topical diclofenac: involvement of matrix metalloproteinases. Ophthalmology. 2003;110(8):1626-1631. IF 9,5
- Javelaud D, Laboureau J, Gabison E, Verrecchia F, Mauviel A. Disruption of basal JNK activity differentially affects key fibroblast functions important for wound healing. J Biol Chem. 2003;278(27):24624-24628. IF 3,9
- Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. [Metalloproteinases and angiogenesis]. Pathol Biol (Paris). 2003;51(3):161-166. IF 1,8
- Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S, Azar DT. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 2001;508(2):187-190. IF 3,0
- Lin HC, Chang JH, Jain S, Gabison EE, Kure T, Kato T, Fukai N, Azar DT. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci. 2001;42(11):2517-2524. IF 4,7
- Azar DT, Ang RT, Lee JB, Kato T, Chen CC, Jain S, Gabison E, Abad JC. Laser subepithelial keratomileusis: electron microscopy and visual outcomes of flap photorefractive keratectomy. Curr Opin Ophthalmol. 2001;12(4):323-328. IF 2,6
- Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12(4):242-249. IF 2,6